Latest UCB Stories
HEMEL HEMPSTEAD, England, April 21, 2015 /PRNewswire/ -- EUSA Pharma (EUSA), a recently-established profitable specialty pharmaceutical company with global reach, today
BRUSSELS, April 20, 2015 /PRNewswire/ -- UCB, a global biopharmaceutical company focusing on neurology and immunology treatment and research, is sponsoring a total of 24 data presentations at the 67(th)
GIA announces the release of a comprehensive global report on the CNS Therapeutics.
NEW YORK, Feb. 12, 2015 /PRNewswire/ -- Royalty Pharma is pleased to announce that George Lloyd has been named General Counsel of Royalty Pharma effective immediately.
LONDON, February 10, 2015 /PRNewswire/ -- Report Details What are the commercial prospects for pharmaceutical [https://www.visiongain.com/Pharma/47/Reports
NEW YORK, Jan.
- Atlanta-based Collaboration Will Explore the Potential of Big Data to Help Inform Treatment Decisions for People Living with Epilepsy ATLANTA, Dec.
- 24 UCB-sponsored presentations including new data on VIMPAT® (lacosamide) BRUSSELS, Dec.
BOSTON and NEW YORK, Nov.
- Stoppage; cessation (of labor).
- A standing still or idling (of mills, factories, etc.).